Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Breast Cancer Research and Treatment|May 19, 2016
Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapyCynthia Villarreal-Garza, Juan Enrique Bargallo-Rocha, Enrique Soto-Perez-de-Celis, et al.Current Oncology (Toronto, Ont.)|November 26, 2024
Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30, 6097-6110Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R Muñoz-Montaño, et al.Current Oncology (Toronto, Ont.)|July 28, 2023
Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast CancerAlberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R Muñoz-Montaño, et al.Journal of Global Oncology|December 16, 2017
Clinical and Epidemiological Profile of Breast Cancer in Mexico: Results of the Seguro PopularNancy Reynoso-Noverón, Cynthia Villarreal-Garza, Enrique Soto-Perez-de-Celis, et al.Clinical Breast Cancer|January 10, 2017
Molecular Subtypes and Prognosis in Young Mexican Women With Breast CancerCynthia Villarreal-Garza, Alejandro Mohar, Juan Enrique Bargallo-Rocha, et al.Breast (Edinburgh, Scotland)|February 21, 2015
Outcomes of Hispanic women with lymph-node positive, HER2 positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab in MexicoCynthia Villarreal-Garza, Enrique Soto-Perez-de-Celis, Erika Sifuentes, et al.Frontiers in Oncology|May 14, 2023
Pathogenic variant profile in DNA damage response genes correlates with metastatic breast cancer progression-free survival in a Mexican-mestizo populationRafael Vázquez-Romo, Oliver Millan-Catalan, Erika Ruíz-García, et al.Journal of Geriatric Oncology|April 26, 2018
Clinical characteristics and outcomes of older women with breast cancer in MexicoPaula Cabrera-Galeana, Enrique Soto-Perez-de-Celis, Nancy Reynoso-Noverón, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 17, 2017
A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancerRaúl García-Vazquez, Erika Ruiz-García, Abelardo Meneses García, et al.Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|June 14, 2012
[Evaluation of breast cancer treatment at a tertiary-level institution with Popular Health Insurance in Mexico]Claudia Arce-Salinas, Fernando Ulises Lara-Medina, Alberto Alvarado-Miranda, et al.Pageof 3